Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Paris court fines Servier 2.7 million euros over weight-loss drug:BFM TV

Published 29/03/2021, 10:30
Updated 29/03/2021, 10:35
© Reuters. Olivier Laureau, president of the Pharmaceutical group Servier, arrives to attend the trial of the Mediator drug case in Paris

PARIS (Reuters) - A Paris court on Monday found French drugmaker Servier guilty of manslaughter and deception over weight-loss pill Mediator, and fined it 2.7 million euros ($3.18 million), according to BFM Television.

France's health ministry has said that at least 500 people died of heart valve problems in France because of exposure to the active ingredient in Mediator, a drug which was withdrawn from sale in 2009.

The court on Monday also fined France's drug regulator ANSM 303,000 euros, BFM TV reported.

Servier's press office did not immediately respond to a request from Reuters for comment. Contacted by Reuters, a spokeswoman for ANSM said she could not provide an immediate comment.

Servier has acknowledged in the past that Mediator had serious consequences for some patients and agreed to compensate some victims, but it also said it would fight inaccuracies and false statements

Once licensed as a diabetes treatment, Mediator was widely prescribed as an appetite suppressant to help people lose weight. Its active chemical substance is known as Benfluorex.

The drug was withdrawn from sale in Spain, Italy and the United States around a decade before it was pulled from the French market.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.